Measuring ERCC1 activity may have utility in clinical cancer medicine because one mechanism of resistance to platinum chemotherapy drugs correlates with high ERCC1 activity.
Medir a actividade de ERCC1 pode ser útil en medicina do cancro clínica porque un mecanismo de resistencia a fármacos quimoterápicos de platino correlaciónase coa alta actividade de ERCC1.